Outcomes related to respiratory syncytial virus with an abbreviated palivizumab regimen in children with congenital heart disease: a descriptive analysis

…, CR Popescu, L Shaiba, C Christopherson… - … Open Access Journal, 2019 - cmajopen.ca
Background: It has been hypothesized that 4 doses of palivizumab, a neutralizing monoclonal
antibody against respiratory syncytial virus (RSV), administered during a fixed-date RSV …

[BOOK][B] Transformative Experiences in College: Connections and Community

N Christopherson - 2020 - books.google.com
… Neal Christopherson argues that transformative experiences in college are primarily the …
Christopherson also touches on extracurricular and co-curricular activities, the importance …

Hardware or wetware: What are the possible interactions of pedagogy and technology in the classroom?

KM Christopherson - Teaching of Psychology, 2011 - journals.sagepub.com
Student response systems have received much attention over the past few years. This easy-to-use
technology has been marketed as a great way to enhance the student experience in …

40 Respiratory syncytial virus-related outcomes from an abbreviated palivizumab dose regimen in children with congenital heart disease

…, L Shaibah, C Christopherson… - Paediatrics & Child …, 2019 - academic.oup.com
Background Respiratory Syncytial Virus (RSV) is a leading cause of hospital admission for
acute lower respiratory tract infections (LRTI) in young children. Infants with congenital heart …

42 A risk factor approach is highly effective at selecting 29-34w gestation infants at risk for first season RSV-related admissions–a population study

…, R Taylor, P Lavoie, C Christopherson… - Paediatrics & Child …, 2019 - search.proquest.com
Background RSV palivizumab prophylaxis remains controversial in infants 29-34w GA without
bronchopulmonary dysplasia (BPD). In our RSV Program these infants only qualify if they …

[PDF][PDF] Cavalli, Matthew Christopherson, Anne

C Hunter, S Kurtz - 2014 - commons.und.edu
The ad-hoc committee is analyzing the results of the survey from the senators and other
faculty. There will be more information coming soon. d. Ms. Gjellstad thanked the senators for …

[PDF][PDF] The UTTler Patriot

M Christopherson - core.ac.uk
According to Dr. Mary Fisher, an associate professorofbusinessatUTT, this is a trend at
campuses across the state of Texas, as well. Statewide, an estimated205, 000 womenare …

[PDF][PDF] Confidential

J Claydon, CR Popescu, L Shaiba, C Christopherson… - cmajopen.ca
Background: It has been hypothesized that 4 doses of palivizumab, a neutralizing monoclonal
antibody against respiratory syncytial virus (RSV), administered within fixed season dates …

41 Lessons learned during the practice of a no-conflict of-interest panel-of-three adjudication process in the RSV program

S Sidi, J Claydon, C Christopherson… - Paediatrics & Child …, 2019 - academic.oup.com
Background RSV prophylaxis with palivizumab is restricted to evidence-based indications
in infants at relatively higher hospital admission risk. The RSV Program’s criteria follow CPS …

Membrane proteome analysis of glioblastoma cell invasion

…, L Ly, EK Sykes, RI Christopherson… - … of Neuropathology & …, 2015 - academic.oup.com
Glioblastoma multiforme (GBM) tumor invasion is facilitated by cell migration and degradation
of the extracellular matrix. Invadopodia are actin-rich structures that protrude from the …